SCHEMBL29518641

SCHEMBL29518641

Nc1cccc2cc(S(=O)(=O)O)ccc12

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.62
HSD17B10 Q99714 6/20 0.62
CASP6 P55212 3/20 0.62
CYP2C9 P11712 3/20 0.62
CYP2C19 P33261 3/20 0.62
ATIC P31939 1/20 0.55
TTR P02766 1/20 0.53
TSHR P16473 4/20 0.52
TDP1 Q9NUW8 2/20 0.52
NT5E P21589 3/20 0.50
NSD2 O96028 1/20 0.50
DUSP3 P51452 1/20 0.50
PTPN5 P54829 1/20 0.50
PTPN11 Q06124 1/20 0.50
CYP1A2 P05177 2/20 0.47
HIF1A Q16665 2/20 0.47
PTPRA P18433 1/20 0.47
PTPRB P23467 1/20 0.47
RAPGEF4 Q8WZA2 1/20 0.47
RHOA P61586 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL157169 1.00 ALDH1A1 (0.62) ALDH1A1HSD17B10CASP6CYP2C9CYP2C19
SCHEMBL29941351 1.00 ALDH1A1 (0.62) ALDH1A1HSD17B10CASP6CYP2C9CYP2C19
SCHEMBL28471751 0.98 ALDH1A1 (0.60) ALDH1A1HSD17B10CASP6CYP2C9CYP2C19
SCHEMBL3246907 0.98 ALDH1A1 (0.60) ALDH1A1HSD17B10CASP6CYP2C9CYP2C19
Water SCHEMBL7704455 0.98 ALDH1A1 (0.60) ALDH1A1HSD17B10CASP6CYP2C9CYP2C19
SCHEMBL9311654 0.94 HSD17B10 (0.69) ALDH1A1HSD17B10CASP6CYP2C9CYP2C19
SCHEMBL3373422 0.91 TTR (0.71) ALDH1A1HSD17B10CASP6CYP2C9CYP2C19
SCHEMBL8030849 0.91 HSD17B10 (0.53) ALDH1A1HSD17B10CASP6CYP2C9CYP2C19
SCHEMBL10703360 0.87 TTR (0.65) ALDH1A1HSD17B10CASP6CYP2C9CYP2C19
SCHEMBL7528317 0.86 HSD17B10 (0.51) ALDH1A1HSD17B10CASP6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4665417-A1 IN SITU GELLING LIQUID EMBOLIC FORMULATIONS AND RELATED METHODS Biosphere Medical, S.A. (FR) 2025-12-24 EP disclosed
WO-2024218102-A1 MODIFICATION OF AROMATIC POLYMERS PREFERE RESINS HOLDING GMBH (DE) 2024-10-24 WO disclosed
EP-4450530-A1 MODIFIED RESINS BASED ON RESINOUS OLIGOMERIC OR POLYMERIC PHENOLIC MATERIALS Prefere Resins Holding GmbH (DE) 2024-10-23 EP disclosed
WO-2024170683-A1 IN SITU GELLING LIQUID EMBOLIC FORMULATIONS AND RELATED METHODS BIOSPHERE MEDICAL, S.A. (FR) 2024-08-22 WO disclosed
EP-4069643-A1 METHODS AND SYSTEMS FOR MONITORING OR CONTROLLING ANTI-SCALANT CONCENTRATION Kemira OYJ (FI) 2022-10-12 EP disclosed
EP-4065150-A1 LONG-ACTING VEGF INHIBITORS FOR INTRAOCULAR NEOVASCULARIZATION The Regents of the University of California (US) 2022-10-05 EP disclosed
EP-3987595-A1 SELECTIVELY PERMEABLE NANOSTRUCTURED MATERIALS Conamix Inc. (US) 2022-04-27 EP disclosed
WO-2022072401-A1 SMALL MOLECULE INHIBITORS OF CORONAVIRUS ATTACHMENT AND ENTRY, METHODS AND USES THEREOF UNIVERSITY OF MIAMI (US) 2022-04-07 WO disclosed